Roselabs Bioscience Profile
Key Indicators
- Authorised Capital ₹ 29.00 Cr
as on 07-12-2024
- Paid Up Capital ₹ 28.90 Cr
as on 07-12-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 462.38 Cr
as on 07-12-2024
- Satisfied Charges ₹ 14.62 Cr
as on 07-12-2024
- Revenue -55.92%
(FY 2020)
- Profit 33.78%
(FY 2020)
- Ebitda 324.38%
(FY 2020)
- Net Worth -122.27%
(FY 2020)
- Total Assets -7.27%
(FY 2020)
About Roselabs Bioscience
The Corporate was formerly known as Roselabs Bioscience Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 29.00 Cr and a paid-up capital of Rs 28.90 Cr.
The company currently has active open charges totaling ₹462.38 Cr. The company has closed loans amounting to ₹14.62 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pawankumar Agrawal, Zameer Agrawal, and Rahul Agrawal serve as directors at the Company.
- CIN/LLPIN
U24290GJ2010PLC059109
- Company No.
059109
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Jan 2010
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Roselabs Bioscience Limited offer?
Roselabs Bioscience Limited offers a wide range of products and services, including Mobile Phone & Accessories, Mobile Tablet.
Who are the key members and board of directors at Roselabs Bioscience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawankumar Agrawal  | Director | 06-Jan-2010 | Current |
| Zameer Agrawal | Director | 06-Jan-2010 | Current |
| Rahul Agrawal | Director | 21-May-2016 | Current |
Financial Performance and Corporate Structure Insights of Roselabs Bioscience.
Roselabs Bioscience Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 55.92% decrease. The company also saw a substantial improvement in profitability, with a 33.78% increase in profit. The company's net worth observed a substantial decline by a decrease of 122.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Roselabs Bioscience?
In 2020, Roselabs Bioscience had a promoter holding of 27.40% and a public holding of 72.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Roselabs LimitedActive 29 years 9 monthsPawankumar Agrawal, Zameer Agrawal and 1 more are mutual person
- Roselabs Polymers LimitedActive 13 years 8 months
Pawankumar Agrawal, Zameer Agrawal and 1 more are mutual person
- Pushpdant Commotrade Private LimitedActive 14 years 5 months
Pawankumar Agrawal and Zameer Agrawal are mutual person
- Gopalka Motor Investo Pvt. Ltd.Active 35 years 5 months
Pawankumar Agrawal and Zameer Agrawal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 28 Jun 2013 | ₹71.38 Cr | Open |
Axis Bank Limited Creation Date: 01 Sep 2012 | ₹1.76 M | Open |
State Bank Of India Creation Date: 11 Jun 2012 | ₹29.74 Cr | Open |
How Many Employees Work at Roselabs Bioscience?
Roselabs Bioscience has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Roselabs Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Roselabs Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
